Navigation Links
International consortium discovers seven new genomic regions associated with AMD
Date:3/3/2013

(Boston) An international group of researchers has discovered seven new regions of the human genomecalled locithat are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness. The AMD Gene Consortium, a network of international investigators representing 18 research groups, also confirmed 12 loci identified in previous studies. The study, which is published online in Nature Genetics and represents the most comprehensive genome-wide analysis of genetic variations associated with AMD, was supported by the National Eye Institute (NEI), a part of the National Institutes of Health.

Lindsay A. Farrer, PhD, chief of the biomedical genetics section and professor at Boston University Schools of Medicine (BUSM) and Public Health (BUSPH), is co-lead author of the study.

"This compelling analysis by the AMD Gene Consortium demonstrates the enormous value of effective collaboration," said NEI Director Paul A. Sieving, MD, PhD. "Combining data from multiple studies, this international effort provides insight into the molecular basis of AMD, which will help researchers search for causes of the disease and will inform future development of new diagnostic and treatment strategies."

Since the 2005 discovery that certain variations in the gene for complement factor Ha component of the immune systemare associated with major risk for AMD, research groups around the world have conducted genome-wide association studies to identify other loci that affect AMD risk. These studies were made possible by tools developed through the Human Genome Project, which mapped human genes, and related projects, such the International HapMap Project, which identified common patterns of genetic variation within the human genome.

The AMD Gene Consortium combined data from 18 research groups to increase the power of prior analyses. The current analysis identified seven new loci near genes. As with the previously d
'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 11th International Congress on Targeted Anticancer Therapies
2. WPI Biomedical Technology in final 4 of international business plan contest
3. Biologists lead international team to track Arctic response to climate change
4. International space station plays host to innovative infectious disease research
5. Maris presentation tops ANZFSS International Symposium
6. International biodiversity data symposium to mark the kickoff of the EU BON project
7. AERA announces publication of the International Handbook of Research on Environmental Education
8. Conference Programme Committees selected for the 20th International AIDS Conference (AIDS 2014)
9. Winners of 10th annual International Science & Technology Visualization Challenge announced
10. The 2013 International Conference on Genomics in Europe will take place in Ghent, Belgium
11. Flashback Data Remains Only Non-Governmental Digital Forensics Lab with ASCLD/LAB International Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 17, 2013 An international team led by scientists ... Medical Institute and Albert Einstein College of Medicine of ... compound that attacks the tuberculosis (TB) bacterium in two ... help solve one of the major global health crises ... drug-resistant strains," said Peter G. Schultz, the Scripps Family ...
(Date:6/17/2013)... Wayne State University,s Department of Physics kicked off ... for Undergraduates (REU) program. This program aims to ... in astrophysics, and in particle and nuclear physics. ... of physics in Wayne State,s College of Liberal ... the grant, the student participants will work with ...
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Wayne State welcomes undergraduates from around the US for physics research experience 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... United States, smart growth proponents have urged communities to ... standard and familiar sprawl. Cluster developments create a ... portion of the land area than dispersed houses. ... open space, farmland, and rural character. Yet few ...
... D.C., Oct. 24, 2007 The vast majority ... the percutaneous MitraClip device did not need mitral ... many benefited from significantly improved function of the ... to data presented this week at the Cardiovascular ...
... priorities for biodiversity often focuses only on the numbers ... hemisphere or in the tropics. But what about ... the world, where the species richness of flowering plants ... UK and Chilean taxonomists, ecologists, and philosophers explored the ...
Cached Biology News:Location, location, location 2Location, location, location 3New data shows benefits of MitraClip for patients with mitral regurgitation 2New data shows benefits of MitraClip for patients with mitral regurgitation 3The conservation lens 2The conservation lens 3
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
(Date:6/18/2013)... June 18, 2013 As a ... Inc proudly announces the release of their infographic ... Fitness ". , MeMD's goal was to leverage ... of Health 2.0, Health 3.0 and mHealth.The infographic ... transform medical care and the fitness industry in ...
Breaking Biology Technology:Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... ISELIN, N.J., Feb. 26 SyntheMed, Inc. (OTC,Bulletin ... development,and commercialization of anti-adhesion products, drug delivery products ... Hickey, President,and CEO, will present at the Canaccord ... 3:30 p.m. PST in San Francisco, CA. Mr.,Hickey ...
... 26 Replidyne, Inc.,(Nasdaq: RDYN ) today announced its ... 31, 2007., Replidyne reported a net loss of $16.9 ... net loss per basic and diluted common share,of $0.63 per ... $0.36 per,basic and diluted common share, for the quarter ended ...
... published in February issue of Clinical and Vaccine Immunology, ... NanoBio,Corporation and the University of Michigan have demonstrated their ... the,potentially lethal dose of smallpox, and without the safety ... to smallpox virus,and builds immunity against it., The ...
Cached Biology Technology:Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Biology Products: